DISCOUNT ZERTIFIKAT - BRISTOL-MYERS SQUIBB | Market Closed - Boerse Frankfurt Warrants 18:53:52 14/06/2024 BST | ||
| 36.49 EUR | +0.41% |
|
| Current month | +3.14% | ||
| 1 month | -4.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 36.49 | +0.41% |
| 13/06/24 | 36.34 | -1.20% |
| 12/06/24 | 36.78 | -1.47% |
| 11/06/24 | 37.33 | +1.47% |
| 10/06/24 | 36.79 | +2.91% |
Real-time Boerse Frankfurt Warrants
Last update June 14, 2024 at 06:53 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VD39R6 |
| ISIN | DE000VD39R63 |
| Date issued | 18/04/2024 |
| Maturity | 21/03/2025 (279 Days) |
| Parity | 1 : 1 |
| Emission price | 40.42 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 40.82 € |
|---|---|
| Lowest since issue | 34.82 € |
| Spread | 0.06 € |
| Spread % | 0.17% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.2
USD
Average target price
53.19
USD
Spread / Average Target
+29.11%
- Stock Market
- Certificates
- Certificat